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A B S T R A C T   
Purpose: The COVID-19 pandemic and related lockdown measures drastically changed health care and emergency 
services utilization. This study evaluated trends in emergency department (ED) access for seizure-related reasons 
in the first 8 weeks of lockdown in Italy. 
Methods: All ED accesses of children (<14 years of age) at two university hospitals, in Turin and Rome, Italy, 
between January 6, 2020 and April 21, 2020, were examined and compared with the corresponding periods of 
2019. 
Results: During the COVID-19 lockdown period (February 23-April 21, 2020), there was a 72 % decrease in all 
pediatric ED accesses over the corresponding 2019 period (n = 3,395 vs n = 12,128), with a 38 % decrease in 
seizure-related accesses (n = 41 vs n = 66). The observed decrease of seizure-related ED accesses was not 
accompanied by significant changes in age, sex, type of seizure, or hospitalization rate after the ED visit. 
Conclusion: The COVID-19 lockdown was accompanied by a sudden decrease in seizure-related hospital emer-
gency visits. School closure, social distancing, reduced risk of infection, and increased parental supervision are 
some of the factors that might have contributed to the finding.   
1. Introduction 
The coronavirus disease (COVID-19) pandemic abruptly changed life 
worldwide with profound implications for healthcare delivery [1]. Italy 
was the first European country to be struck by COVID-19. On February 
23, 2020, in an effort to contain the contagion, schools were closed, 
followed by all non-essential businesses and services, so that the entire 
Italian population was put on a strict lockdown [2,3]. The impact on 
health care services was dramatic, with rapid redirection of resources to 
the management of COVID-19 patients, postponement of all non-urgent 
care, suspension of routine outpatient services, and significant decrease 
in hospital utilization for conditions other than COVID-19 [4,5]. How-
ever, access to hospital emergency departments (ED) for severe medical 
conditions such as seizures would not be expected to change. 
We here report on a significant decrease in ED accesses for pediatric 
seizure-related reasons at two pediatric hospitals in Turin and Rome, 
Italy, during the first 8 weeks of the COVID-19 related lockdown. 
2. Methods 
All ED accesses by children under 14 years of age at two university 
hospitals in Italy (Regina Margherita Pediatric Hospital in Turin and 
Policlinico Umberto I University Hospital in Rome) between January 6 
and April 19, 2020, and the corresponding period in 2019 (January 7 – 
April 21) were examined. The combined catchment area of the two 
hospitals is about 3 million people. All visits requiring a child neurolo-
gist consult were identified and manually reviewed for seizure-related 
conditions [6]. Seizure-related ED accesses were sub-grouped into five 
categories: status epilepticus, febrile seizure (including febrile status 
epilepticus), seizure in patient without a diagnosis of epilepsy, 
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recurrence of seizure in patients with diagnosis of epilepsy, and parox-
ysmal movements [7]. Patients with known psychogenic non-epileptic 
seizures (PNES) were excluded (only 1 case of PNES was present in 
the first period of 2020). Hospital inpatient admission subsequent to ED 
access was recorded as an index of clinical relevance and severity. 
Based on the date of February 24, when the COVID-19 lockdown 
began, the two periods (January 6 - April 19, 2020 and January 7 - April 
21, 2019) were divided into two intervals each: “pre-COVID-19” (i.e., 
until February 23, 2020 or February 24, 2019) and “post-COVID-19” 
afterwards. For both 2019 and 2020, the period of observation was of 15 
weeks (thus explaining why the period ends on April 19 in 2020 and on 
April 21 in 2019). The study was approved by the institutional ethics 
committee. The data were anonymously recorded and analyzed. 
2.1. Statistical analysis 
Weekly ED access counts were modeled using a Poisson regression 
model. A COVID-19-related covariate assumed the value of 0 until 
February 23 and the value of 1 thereafter in order to evaluate the impact 
of the COVID-19 lockdown. The same model, with an offset equivalent 
to the logarithm of all ED accesses per week, was used to evaluate the 
trend in seizure-related ED accesses adjusting by total ED accesses. Non- 
parametric statistics (chi-square test, with Williams’s correction when 
appropriate, and Mann-Whitney U test) were used to test for differences 
in demographics and clinical variables between the observed time- 
intervals. Alpha was set at two-tailed 0.05. 
3. Results 
Total pediatric ED accesses for any reason were n = 14,239 between 
January 6 and April 19, 2020, and n = 23,016 during the corresponding 
period in 2019. Among these, seizure-related ED accesses were n = 128 
in 2020 vs. n = 136 in 2019. Mean age was 5.77 ± 4.31 years in 2020 
(SD: 4.31; median: 4.94, IQR: 2.01–9.05) and 6.38 ± 4.26 years (me-
dian: 6.53, IQR: 2.38–9.89) in 2019. Males were 55 % in 2020 and 45 % 
in 2019. Weekly seizure-related ED visits decreased after February 23, 
2020 over the previous weeks in 2020 and compared with the corre-
sponding period of 2019 (Fig. 1A). Specifically, in the Poisson regression 
model, the COVID-19 lockdown factor was associated with a 59 % 
decrease in seizure-related accesses compared to the corresponding 
period of 2019 (41 visits in the second interval in 2020 vs 66 in 2019, p 
< 0.001, Table 1). 
Total pediatric ED accesses were n = 3,395 (2,326 in Turin and 1,069 
in Rome) in the COVID-19 period, a 3.6-fold decline over the corre-
sponding period of 2019 (n = 12,128, 7630 in Turin and 4,498 in Rome). 
Seizure-related ED accesses accounted for a larger proportion of all ED 
pediatric accesses during the COVID-19 period (xx%) as compared to the 
corresponding period of 2019 (xy%). In the Poisson regression model, 
the COVID-19 lockdown factor was associated with an incidence rate 
ratio (IRR) 0.41 (95 % CI 0.28 – 0.59) compared to the 2019 period 
(Table 1, Fig. 1B). 
The distribution of seizure type did not show statistically significant 
changes in the COVID-19 lockdown (Fig. 1C), χ2 = 2.78 (df = 4), p =
0.60. In particular, 39 % of all seizure-related accesses were for seizures 
in patients already diagnosed with epilepsy (vs 30 % in the corre-
sponding period of 2019), 44 % for seizures in patients without a 
diagnosis of epilepsy (vs 41 % in 2019), 7% for febrile seizures (vs. 18 % 
in 2019), 7% for paroxysmal events (vs. 7% in 2019), and 2 % for status 
epilepticus (vs. 3 % in 2019). 
The rate of hospitalization following the ED visit did not significantly 
change during the COVID-19 lockdown (49 % vs 50 % in 2019). No sex 
or age differences were found between 2020 and 2019 accesses. 
4. Discussion 
We observed a 38 % decrease in ED accesses for seizure-related 
reasons during the COVID-19 lockdown period compared with the 
Fig. 1. A: Weekly number of seizure-related visits in the observed periods of 
2019 and 2020. B: Weekly percentage distribution of seizure-related visits and 
ED pediatric accesses (weekly seizure-related visits over total seizure related 
visits of the entire period, blue; weekly ED pediatric accesses over ED pediatric 
accesses of the entire period, red) in observed period in 2020. C: Percentage 
distribution of type of seizure event during the COVID-19 period in (2nd in-
terval 2020). (For interpretation of the references to colour in this figure 
legend, the reader is referred to the web version of this article). 
Table 1 
Impact of COVID-19 lockdown on ED visits for seizure-related events.   
Outcome - number 
of n visits per week 
Comparison IRR 95 % CI 
2nd interval 2020 vs 1st interval 2020 0.41 0.28 - 0.59 
2nd interval 2020 vs 2nd interval 2019 0.41 0.28 - 0.58 
2nd interval 2020 vs 1st interval 2020 (adjusted by ED total) 1.51 1.03–2.17 
2nd interval 2020 vs 2nd interval 2019 (adjusted by ED total) 1.53 1.05–2.19 
IRR: incidence rate ratio. 
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corresponding 2019 time-period. This decrease was less marked than the 
72 % decline in all ED pediatric accesses, a difference that underscores 
the clinical relevance of seizures as medical emergency. In fact, the 
proportion of total ED accesses due to seizures increased by 51 % over 
2019 (Table 1). Hospitalization rate following the ED visit, a possible 
index of clinical severity, did not significantly change, suggesting that 
there was not a self-selection based on advanced care needs. 
A general reduction in ED use can be expected at a time of pandemic 
and in part ascribed to avoidance of hospital settings for fear of conta-
gion. Under these circumstances, inappropriate use of ED services for 
non-urgent care is likely to decrease. Concern has been raised, however, 
that the COVID-19 crisis might have resulted in the opposite problem of 
ED underuse, with hospital avoidance even in cases of serious medical 
problems [4,5]. In fact, one would not expect a reduction of urgent care 
for conditions such as newly onset seizures. Thus, the observed decrease 
appears puzzling and not fully explained by known contextual variables. 
A seasonality in seizure-related events is expected, being linked to 
the seasonality of common infections such as influenza [8]. Thus, inci-
dence of febrile seizures is higher [9,10]. However, the observed 
decrease in ED accesses for seizure-related reasons during the COVID-19 
lockdown greatly exceeds the seasonally expected reduction, and is also 
evident when it is compared with the corresponding 2019 time-period. 
The reduction in ED seizure-related accesses could be in part explained 
by a possible decrease in infections since the COVID-19 lockdown 
greatly curtailed social contacts by closing schools, prohibiting group 
activities and imposing social distancing. 
More difficult to explain is the dramatic reduction in ED accesses for 
seizures not apparently linked to infections. Did the incidence of seizures 
in fact decline during the COVID-19 lockdown through still unknown 
mechanisms? A few hypotheses can be formulated about possible 
mechanisms of seizure reduction in patients with epilepsy. As the 
lockdown resulted in closure of most work activities, the time parents 
spent at home with their children increased and this could have resulted 
in better supervision and medication compliance [11]. Also, school 
closure could have reduced sleep deprivation, a risk factor for seizures. 
Alternatively, did the incidence remain unchanged but children with 
seizures were not brought to hospital EDs and instead managed at home 
or in other settings? School closure might have increased home man-
agement of seizures by parents. That seizures were managed in other 
non-hospital medical settings seems to be unlikely. During the lockdown 
access to medical offices and outpatient clinics was greatly reduced. 
Outpatient offices appear in any case to be unwieldy settings for man-
aging seizures. The possibility that more patients were treated at other, 
smaller and lower-volume hospitals may be considered. However, access 
to these local hospitals, which typically serve both adults and children, 
would have entailed a higher COVID-19 exposure risk than tertiary-care 
pediatric facilities. In fact, some of these smaller hospitals became 
COVID-19 wards during the pandemic acute phase. For these reasons, it 
seems unlikely that parents preferred small hospitals for their children 
with acute seizures. 
Telemedicine has been increasingly used for a variety of clinical is-
sues, but seems an unlikely means for managing status epilepticus or 
newly onset seizures. At our hospitals, we did not notice a higher volume 
of phone or online contacts for neurologic emergencies. In a few cases, 
telemedicine helped to instruct parents on the value of ED assessment as 
seizure-related risks outweighed COVID-19 exposure risk. 
Thus the question remains why so many children with seizures seem 
to have suddenly disappeared. Trying to answer this question may shed 
light on still unknown risk and protective factors for developing seizures 
and possibly help identify alternative ways of managing these 
emergencies. 
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